Management of syncope in adults: An update

Mayo Clinic Proceedings

Volumn 83, Issue 11, 2008, Pages 1280-1293

  Chen, Lin Y ^a   Benditt, David G ^b   Shen, Win Kuang ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MIDODRINE; SEROTONIN UPTAKE INHIBITOR; VERAPAMIL;

CARDIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATHETER ABLATION; CHANNELOPATHY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; COUNTERPULSATION; DEFIBRILLATOR; DEPRESSION; DEVICE; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMERGENCY WARD; FOLLOW UP; HAND GRIP; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; IMPEDANCE; IMPLANTABLE LOOP RECORDER; LABORATORY TEST; LEG EXERCISE; LUNG EMBOLISM; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; MUSCLE TONE; NEUROLOGIC EXAMINATION; PACEMAKER; PHYSICAL EXAMINATION; PREDICTION; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEIZURE; SENSITIVITY AND SPECIFICITY; SINUS NODE DYSFUNCTION; STROKE; SUBARACHNOID HEMORRHAGE; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE; TELEMETRY; TILT TABLE TEST;

EID: 55549131950     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.11.1280     Document Type: Conference Paper

References (72)

1. Brignole M, Alboni P, Benditt DG, et al; Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope - update 2004. Europace. 2004;6(6):467-537.
2. Thijs RD, Benditt DG, Mathias CJ, et al. Unconscious confusion - a literature search for definitions of syncope and related disorders. Clin Auton Res. 2005;15(1):35-39.
3. Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878-885.
4. Lewis DA, Dhala A. Syncope in the pediatric patient: the cardiologist's perspective. Pediatr Clin North Am. 1999;46(2):205-219.
5. Chen LY, Shen W-K, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Prevalence of syncope in a population aged more than 45 years. Am J Med. 2006;119(12):1088.e1-1088.e7. doi:10.1016/j.amjmed.2006.01.029.
6. Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Wieling W. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91(8):1006-1008, A8. doi:10.1016/S0002-9149(03)00127-9.
7. Blanc JJ, L'Her C, Touiza A, Garo B, L'Her E, Mansourati J. Prospective evaluation and outcome of patients admitted for syncope over a 1 year period. Eur Heart J. 2002;23(10):815-820.
8. Brignole M, Disertori M, Menozzi C, et al; Evaluation of Guidelines in Syncope Study (EGSYS) group. Management of syncope referred urgently to general hospitals with and without syncope units. Europace. 2003;5(3):293-298. doi:10.1016/S1099-5129(03)00047-3.
9. Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 1982;73(1):15-23.
10. Silverstein MD, Singer DE, Mulley AG, Thibault GE, Barnett GO. Patients with syncope admitted to medical intensive care units. JAMA. 1982;248(10):1185-1189.
11. Morichetti A, Astorino G. Epidemiological and clinical findings in 697 syncope events [in Italian]. Minerva Med. 1998;89(6):211-220.
12. Calkins H, Byrne M, el-Atassi R, Kalbfleisch S, Langberg JJ, Morady F. The economic burden of unrecognized vasodepressor syncope. Am J Med. 1993;95(5):473-479.
13. Krahn AD, Klein GJ, Yee R, Manda V. The high cost of syncope: cost implications of a new insertable loop recorder in the investigation of recurrent syncope. Am Heart J. 1999;137(5):870-877.
14. Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol. 2005;95(5):668-671.
15. Brignole M, Alboni P, Benditt D, et al; Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 2001;22(15):1256-1306.
16. Strickberger SA, Benson W, Biaggioni I, et al; American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke; Quality of Care and Outcomes Research Interdisciplinary Working Group; American College of Cardiology Foundation in collaboration with the Heart Rhythm Society; American Autonomic Society. AHA/ACCF scientific statement on the evaluation of syncope [published correction appears in Circulation. 2006;113(14):e697]. Circulation. 2006;113(2):316-327.
17. Huff JS, Decker WW, Quinn JV, et al; American College of Emergency Physicians Clinical Policies Committee (Writing Committee) on Syncope. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Ann Emerg Med. 2007;49(4):431-444.
18. Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN; Clinical Efficacy Assessment Project of the American College of Physicians. Diagnosing syncope, Part 1: value of history, physical examination, and electrocardiography. Ann Intern Med. 1997;126(12):989-996.
19. Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN; Clinical Efficacy Assessment Project of the American College of Physicians. Diagnosing syncope, part 2: unexplained syncope. Ann Intern Med. 1997;127(1):76-86.
20. Jhanjee R, van Dijk JG, Sakaguchi S, Benditt DG. Syncope in adults: terminology, classification, and diagnostic strategy. Pacing Clin Electrophysiol. 2006;29(10):1160-1169.
21. Brignole M. Diagnosis and treatment of syncope. Heart. 2007;93(1):130-136.
22. Chen LY, Shen WK. Neurocardiogenic syncope: latest pharmacological therapies. Expert Opin Pharmacother. 2006;7(9):1151-1162.
23. Kenny RA, O'Shea D, Walker HF. Impact of a dedicated syncope and falls facility for older adults on emergency beds. Age Ageing. 2002;31(4):272-275.
24. Thijs RD, Wieling W, Kaufmann H, van Dijk G. Defining and classifying syncope. Clin Auton Res. 2004;14(suppl 1):14-18.
25. Chen LY, Gersh BJ, Hodge DO, Wieling W, Hammill SC, Shen WK. Prevalence and clinical outcomes of patients with multiple potential causes of syncope. Mayo Clin Proc. 2003;78(4):414-420.
26. Krediet CT, van Dijk N, Linzer M, van Lieshout JJ, Wieling W. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation. 2002;106(13):1684-1689.
27. Brignole M, Croci F, Menozzi C, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol. 2002;40(11):2053-2059.
28. van Dijk N, Quartieri F, Blanc J-J, et al; PC-Trial Investigators. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol. 2006 Oct 17;48(8):1652-1657. Epub 2006 Sep 26.
29. Melby DP, Lu F, Sakaguchi S, Zook M, Benditt DG. Increased impedance to inspiration ameliorates hemodynamic changes associated with movement to upright posture in orthostatic hypotension: a randomized blinded pilot study. Heart Rhythm. 2007 Feb;4(2):128-135. Epub 2006 Oct 19.
30. Shen WK, Decker WW, Smars PA, et al. Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management. Circulation. 2004 Dec 14;110(24):3636-3645. Epub 2004 Nov 9.
31. Del Greco M, Cozzio S, Scillieri M, Caprari F, Scivales A, Disertori M. Diagnostic pathway of syncope and analysis of the impact of guidelines in a district general hospital: the ECSIT study (epidemiology and costs of syncope in Trento). Ital Heart J. 2003;4(2):99-106.
32. Ammirati F, Colivicchi F, Santini M. Diagnosing syncope in clinical practice: implementation of a simplified diagnostic algorithm in a multicentre prospective trial-the OESIL 2 study (Osservatorio Epidemiologico della Sincope nel Lazio). Eur Heart J. 2000;21(11):935-940.
33. Colivicchi F, Ammirati F, Melina D, Guido V, Imperoli G, Santini M; OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J. 2003;24(9):811-819.
34. Elesber AA, Decker WW, Smars PA, Hodge DO, Shen W-K. Impact of the application of the American College of Emergency Physicians recommendations for the admission of patients with syncope on a retrospectively studied population presenting to the emergency department. Am Heart J. 2005;149(5):826-831.
35. American College of Emergency Physicians. Clinical policy: critical issues in the evaluation and management of patients presenting with syncope. Ann Emerg Med. 2001;37(6):771-776.
36. Croci F, Brignole M, Alboni P, et al. The application of a standardized strategy of evaluation in patients with syncope referred to three syncope units. Europace. 2002;4(4):351-355.
37. Benditt DG, Lu F, Lurie KG, Sakaguchi S. Organisation of syncope management units: the North American experience. In: Raviele A, ed. Cardiac Arrhythmias 2005. Milan, Italy: Springer-Verlag Italia; 2006:655-658. doi:10.1007/88-470-0371-7_80.
38. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20(4):457-464.
39. Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA, Wells GA. Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. Ann Emerg Med. 2004;43(2):224-232.
40. Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006 May;47(5):448-454. Epub 2006 Jan 18.
41. Sun BC, Mangione CM, Merchant G, et al. External validation of the San Francisco Syncope Rule. Ann Emerg Med. 2007 Apr;49(4):420-427, 427.e1-427.e4. Epub 2007 Jan 8.
42. Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med. 1995;98(4):365-373.
43. Alboni P, Brignole M, Menozzi C, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001;37(7):1921-1928.
44. Del Rosso A, Alboni P, Brignole M, Menozzi C, Raviele A. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005 Nov 15;96(10):1431-1435. Epub 2005 Sep 27.
45. Sheldon R, Rose S, Ritchie D, et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002;40(1):142-148.
46. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M. Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J. 2006 Feb;27(3):344-350. Epub 2005 Oct 13.
47. Bartoletti A, Fabiani P, Adriani P, et al. Hospital admission of patients referred to the Emergency Department for syncope: a single-hospital prospective study based on the application of the European Society of Cardiology Guidelines on syncope. Eur Heart J. 2006 Jan;27(1):83-88. Epub 2005 Aug 25.
48. Brignole M, Menozzi C, Bartoletti A, et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J. 2006 Jan;27(1):76-82. Epub 2005 Nov 4.
49. Brignole M, Ungar A, Bartoletti A, et al; Evaluation of Guidelines in Syncope Study 2 (EGSYS-2) group. Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace. 2006;8(8):644-650.
50. Gibson TC, Heitzman MR. Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol. 1984;53(8):1013-1017.
51. Kapoor WN. Evaluation and management of the patient with syncope. JAMA. 1992;268(18):2553-2560.
52. Krahn AD, Klein GJ, Norris C, Yee R. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation. 1995;92(7):1819-1824.
53. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C; Reveal Investigators. Use of an extended monitoring strategy in patients with problematic syncope. Circulation. 1999;99(3):406-410.
54. Moya A, Brignole M, Menozzi C, et al; International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104(11):1261-1267.
55. Nierop PR, van Mechelen R, van Elsäcker A, Luijten RH, Elhendy A. Heart rhythm during syncope and presyncope: results of implantable loop recorders. Pacing Clin Electrophysiol. 2000;23(10, pt 1):1532-1538.
56. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104(1):46-51.
57. Fujimura O, Yee R, Klein GJ, Sharma AD, Boahene KA. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. N Engl J Med. 1989;321(25):1703-1707.
58. Transoma Medical. http://transoma.com/medical_professionals/syncope/ product. Accessed October 14, 2008.
59. Sutton R, Brignole M, Menozzi C, et al; Vasovagal Syncope International Study (VASIS) Investigators. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation. 2000;102(3):294-299.
60. Ammirati F, Colivicchi F, Santini M; Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001;104(1):52-57.
61. Connolly SJ, Sheldon R, Thorpe KE, et al; VPS II Investigators. Pace-maker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003;289(17):2224-2229.
62. Raviele A, Giada F, Menozzi C, et al; Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope: the vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004;25(19):1741-1748.
63. Steering Committee of the ISSUE 2 study. International Study on Syncope of Uncertain Etiology 2: the management of patients with suspected or certain neurally mediated syncope after the initial evaluation rationale and study design. Europace. 2003;5(3):317-321.
64. Brignole M, Sutton R, Menozzi C, et al; International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006 May;27(9):1085-1092. Epub 2006 Mar 28.
65. Steering Committee of the ISSUE 3 Study. International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design. Europace. 2007;9(1):25-30.
66. MacLean AR, Allen EV. Orthostatic hypotension and orthostatic tachycardia: treatment with the "head-up" bed. JAMA. 1940;115:2162-2167.
67. Ector H, Reybrouck T, Heidbüchel H, Gewillig M, Van de Werf F. Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. Pacing Clin Electrophysiol. 1998;21(1, pt 2):193-196.
68. Reybrouck T, Heidbüchel H, Van de Werf F, Ector H. Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol. 2000;23(4, pt 1):493-498.
69. Reybrouck T, Heidbüchel H, Van de Werf F, Ector H. Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol. 2002;25(10):1441-1446.
70. Croci F, Brignole M, Menozzi C, et al. Efficacy and feasibility of isometric arm counter-pressure manoeuvres to abort impending vasovagal syncope during real life. Europace. 2004;6(4):287-291.
71. American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2005 Dec 13;112(24)(suppl):IV1-IV203. Epub 2005 Nov 28. doi:10.1161/CIRCULATIONAHA.105.166550.
72. Thijs RD, Wieling W, van den Aardweg JG, van Dijk JG. Respiratory countermaneuvers in autonomic failure. Neurology. 2007;69(6):582-585.